T-cell large granular lymphocyte leukemia medical therapy: Difference between revisions
(Created page with "{{CMG}} {{T cell large granular lymphocyte leukemia}} ==Overview== ==Medical Therapy== ==Pharmacotherapy=== Alemtuzumab has been investigated for use in treatment of refr...") |
No edit summary |
||
(2 intermediate revisions by one other user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
==Pharmacotherapy=== | ===Pharmacotherapy=== | ||
[[Alemtuzumab]] has been investigated for use in treatment of refractory T-cell large granular lymphocytic leukemia.<ref name="pmid14976065">{{cite journal |author=Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH |title=Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia |journal=Blood |volume=103 |issue=5 |pages=1969–71 |year=2004 |month=March |pmid=14976065 |doi=10.1182/blood-2003-11-3951 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=14976065}}</ref> | [[Alemtuzumab]] has been investigated for use in treatment of refractory T-cell large granular lymphocytic leukemia.<ref name="pmid14976065">{{cite journal |author=Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH |title=Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia |journal=Blood |volume=103 |issue=5 |pages=1969–71 |year=2004 |month=March |pmid=14976065 |doi=10.1182/blood-2003-11-3951 |url=http://www.bloodjournal.org/cgi/pmidlookup?view=long&pmid=14976065}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:Hematology|T-cell large granular lymphocyte leukemia]] | |||
[[Category:Types of cancer|T-cell large granular lymphocyte leukemia]] |
Latest revision as of 16:43, 30 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
T-cell large granular lymphocyte leukemia Microchapters |
Differentiating T-cell large granular lymphocyte leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell large granular lymphocyte leukemia medical therapy On the Web |
American Roentgen Ray Society Images of T-cell large granular lymphocyte leukemia medical therapy |
FDA on T-cell large granular lymphocyte leukemia medical therapy |
CDC on T-cell large granular lymphocyte leukemia medical therapy |
T-cell large granular lymphocyte leukemia medical therapy in the news |
Blogs on T-cell large granular lymphocyte leukemia medical therapy |
Risk calculators and risk factors for T-cell large granular lymphocyte leukemia medical therapy |
Overview
Medical Therapy
Pharmacotherapy
Alemtuzumab has been investigated for use in treatment of refractory T-cell large granular lymphocytic leukemia.[1]
References
- ↑ Rosenblum MD, LaBelle JL, Chang CC, Margolis DA, Schauer DW, Vesole DH (2004). "Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia". Blood. 103 (5): 1969–71. doi:10.1182/blood-2003-11-3951. PMID 14976065. Unknown parameter
|month=
ignored (help)